Our findings suggest that under obesogenic conditions, CD146 is expressed on a subtype of ATMs and associates with Gp130 to maintain the M1‐like pro‐inflammatory phenotype and promotes the development of dietary obesity and adipose inflammation, leading to systemic insulin resistance. Here, MCAM is linked to obesity disorder.